M. Iñarrairaegui

发表

[Diagnosis of small hepatocellular carcinoma].

B. Sangro, M. Iñarrairaegui, 2007, Gastroenterologia y hepatologia.

The joint use of 99mTc-MAA-SPECT/CT and cone-beam CT optimizes radioembolization planning

B. Sangro, J. Bilbao, V. Morán, 2021, EJNMMI Research.

Informed consent document in gastrointestinal endoscopy: understanding and acceptance by patients.

J. Vila, M. Iñarrairaegui, F. Jiménez, 2006, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Trial of complete weaning from immunosuppression for liver transplant recipients: Factors predictive of tolerance

B. Sangro, J. Quiroga, J. Herrero, 2013, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Totally Laparoscopic Right Hepatectomy for Living Donor Liver Transplantation: Analysis of a Preliminary Experience on 5 Consecutive Cases

B. Sangro, F. Rotellar, I. Herrero, 2017, Transplantation.

Radioembolization with 90Y-microspheres for liver tumors☆

M. Rodríguez-Fraile, M. Iñarrairaegui, 2015 .

adioembolización de tumores hepáticos con 90Y-microesferas

M. Rodríguez-Fraile, M. Iñarrairaegui, Manuel Rodríguez, 2015 .

Unexpected early tumor recurrence in patients with hepatitis C virus -related hepatocellular carcinoma undergoing interferon-free therapy: a note of caution

J. Bruix, X. Forns, B. Sangro, 2016 .

Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy.

J. Bruix, X. Forns, B. Sangro, 2016, Journal of hepatology.

Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma.

B. Sangro, J. Quiroga, F. Rotellar, 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

NatB-mediated protein N-α-terminal acetylation is a potential therapeutic target in hepatocellular carcinoma

Pere Roca-Cusachs, J. Prieto, B. Sangro, 2017, Oncotarget.

Neutrophil-to-lymphocyte ratio predicts survival in European patients with hepatocellular carcinoma administered sorafenib

B. Sangro, J. Arenas, M. Iñarrairaegui, 2017, Oncotarget.

Risk factors of lung, head and neck, esophageal, and kidney and urinary tract carcinomas after liver transplantation: The effect of smoking withdrawal

B. Sangro, J. Quiroga, F. Rotellar, 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Prognosis of Hepatocellular Carcinoma in Relation to Treatment Across BCLC Stages

J. Prieto, B. Sangro, J. Quiroga, 2011, Annals of Surgical Oncology.

Decreased Long‐Term Severe Acute Respiratory Syndrome Coronavirus 2–Specific Humoral Immunity in Liver Transplantation Recipients 12 Months After Coronavirus Disease 2019

G. Blanco-Fernández, V. Cuervas-Mons, S. Tomé, 2022 .

Liver disease induced by radioembolization of liver tumors

B. Sangro, J. Bilbao, I. Sola, 2008, Cancer.

Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules.

J. Bruix, X. Forns, B. Sangro, 2019, Journal of hepatology.

Web-based formative assessment through clinical cases: role in pathophysiology teaching

J. Herrero, M. Landecho, M. Iñarrairaegui, 2021, BMC medical education.

Radioembolization for Hepatocellular Carcinoma: Evidence-Based Answers to Frequently Asked Questions

B. Sangro, M. Iñarrairaegui, 2011 .

Pilot randomized trial of selective internal radiation therapy vs. chemoembolization in unresectable hepatocellular carcinoma

A. Haug, B. Sangro, F. Kolligs, 2015, Liver international : official journal of the International Association for the Study of the Liver.

Selective Internal Radiation Therapy Approval for Early HCC: What Comes Next?

B. Sangro, M. Iñarrairaegui, 2021 .

Radioembolization as an adjunct therapy to the resection of liver tumors.

B. Sangro, M. Iñarrairaegui, 2015, Hepatic oncology.

Reply to: "Pre-therapeutic dosimetry evaluation and selective internal radiation therapy of hepatocellular carcinoma using yttrium-90-loaded microspheres".

B. Sangro, J. Bilbao, M. Iñarrairaegui, 2013, Journal of hepatology.

Pure laparoscopic major liver resection after yttrium90 radioembolization: a case-matched series analysis of feasibility and outcomes

B. Sangro, F. Rotellar, J. Bilbao, 2022, Langenbeck's Archives of Surgery.

Safety and Efficacy Assessment of Flow Redistribution by Occlusion of Intrahepatic Vessels Prior to Radioembolization in the Treatment of Liver Tumors

B. Sangro, J. Bilbao, Javier Rodríguez, 2010, CardioVascular and Interventional Radiology.

Drug Liver Injury Induced by Olmesartan Mediated by Autoimmune-Like Mechanism: A Case Report

M. Iñarrairaegui, Manuel de la Torre-Aláez, 2020, European journal of case reports in internal medicine.

Hepatic encephalopathy after liver transplantation in a patient with a normally functioning graft: Treatment with embolization of portosystemic collaterals

J. Quiroga, J. Herrero, J. Bilbao, 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Radioembolization of hepatocellular carcinoma activates liver regeneration, induces inflammation and endothelial stress and activates coagulation

B. Sangro, J. Quiroga, M. Ávila, 2015, Liver international : official journal of the International Association for the Study of the Liver.

Treatment of murine fulminant hepatitis with genetically engineered endothelial progenitor cells.

J. Prieto, C. Qian, B. Sangro, 2011, Journal of hepatology.

Evaluation of the quality of multiple-choice questions according to the students’ academic level

J. Herrero, N. Fernández-Ros, M. Landecho, 2022, BMC Medical Education.

Nivolumab after selective internal radiation therapy for the treatment of hepatocellular carcinoma: a phase 2, single-arm study

B. Sangro, J. Bilbao, J. Arenas, 2022, Journal for immunotherapy of cancer.

Liver Radioembolization Using 90Y Resin Microspheres in Elderly Patients: Tolerance and Outcome

B. Sangro, J. Bilbao, A. Benito, 2010, Hospital practice.

Radioembolization: Concepts and Procedures

B. Sangro, J. Arbizu, J. Bilbao, 2013 .

Segmental Pneumonitis after Radioembolization.

B. Sangro, L. Sancho, M. Rodríguez-Fraile, 2018, Journal of vascular and interventional radiology : JVIR.

Hypovitaminosis C as an unexpected cause of bleeding in a cirrhotic patient.

F. Alegre, M. Iñarrairaegui, M. Sogbe, 2022, Medicina clinica.

Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis C virus infection

J. Prieto, B. Sangro, J. Lasarte, 2015, Molecular therapy. Methods & clinical development.

Evaluation of the rabbit liver by direct portography and contrast-enhanced computed tomography: anatomical variations of the portal system and hepatic volume quantification

B. Sangro, J. Bilbao, A. Benito, 2017, European Radiology Experimental.

Immune monitoring of immunosuppression withdrawal of liver transplant recipients.

B. Sangro, J. Quiroga, J. Lasarte, 2015, Transplant immunology.

Neoantigens as potential vaccines in hepatocellular carcinoma

L. Buonaguro, B. Sangro, S. Hervás-Stubbs, 2022, Journal for ImmunoTherapy of Cancer.

Results in Hepatocellular Carcinoma

B. Sangro, M. Iñarrairaegui, 2013 .

Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis

B. Sangro, J. Muntané, M. Ávila, 2019, Hepatology.

Radioembolization for hepatocellular carcinoma.

Bruno Sangro, B. Sangro, J. Bilbao, 2012, Journal of hepatology.

Immune Checkpoint Inhibitors for the Treatment of Hepatocellular Carcinoma

B. Sangro, D. D’Avola, M. Iñarrairaegui, 2017 .

Immunotherapy of Hepatocellular Carcinoma: Facts and Hopes

B. Sangro, I. Melero, M. Iñarrairaegui, 2017, Clinical Cancer Research.

A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C.

J. Prieto, B. Sangro, I. Melero, 2013, Journal of hepatology.

Digestive anisakiasis: clinical manifestations and diagnosis according to localization.

J. Vila, M. Iñarrairaegui, J. Zozaya, 2002, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Pneumatocele during sorafenib therapy: first report of an unusual complication

B. Sangro, J. Zulueta, N. Fernández-Ros, 2017, Oncotarget.

Effectiveness and Safety of Sofosbuvir/Velpatasvir/ Voxilaprevir in Patients with Chronic Hepatitis C Previously Treated with DAAs.

M. Buti, S. Llerena, B. Figueruela, 2019, Journal of hepatology.

Prognostic factors and prevention of radioembolization‐induced liver disease

J. Prieto, B. Sangro, J. Quiroga, 2013, Hepatology.

Radioembolization-Induced Liver Disease

B. Sangro, M. Iñarrairaegui, A. Kennedy, 2013 .

Transarterial therapies for hepatocellular carcinoma

J. Prieto, B. Sangro, D. D’Avola, 2011, Expert opinion on pharmacotherapy.

Treatment of Hepatocellular Carcinoma by Radioembolization Using 90Y Microspheres

B. Sangro, J. Bilbao, M. Iñarrairaegui, 2009, Digestive Diseases.

Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma.

J. Prieto, B. Sangro, J. Quiroga, 2006, International journal of radiation oncology, biology, physics.

Survival after yttrium‐90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: A European evaluation

F. Izzo, B. Sangro, F. Fiore, 2011, Hepatology.

Radioembolization with use of yttrium-90 resin microspheres in patients with hepatocellular carcinoma and portal vein thrombosis.

Kenneth G. Thurston, B. Sangro, D. D’Avola, 2010, Journal of vascular and interventional radiology : JVIR.

Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade.

B. Sangro, W. Yeo, H. Reeves, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chronic hepatitis C virus infection: it is not only about the liver

M. Iñarrairaegui, M Iñarrairaegui, I Elizalde, 2014, European journal of gastroenterology & hepatology.

Changes in humoral immune response after SARS-CoV-2 infection in liver transplant recipients compared to immunocompetent patients

G. Blanco-Fernández, J. Álamo-Martínez, V. Cuervas-Mons, 2021, American Journal of Transplantation.

Phase 1–2 pilot clinical trial in patients with decompensated liver cirrhosis treated with bone marrow–derived endothelial progenitor cells

E. Andreu, F. Prósper, J. Prieto, 2017, Translational research : the journal of laboratory and clinical medicine.

Phase I dose escalation study of nivolumab (Anti-PD-1; BMS-936558; ONO-4538) in patients (pts) with advanced hepatocellular carcinoma (HCC) with or without chronic viral hepatitis.

J. Prieto, B. Sangro, T. Crocenzi, 2013 .

J. Prieto, B. Sangro, G. Frühbeck, 2015, European journal of gastroenterology & hepatology.

Malignant epithelioid hemangioendothelioma of the liver successfully treated with Sorafenib

B. Sangro, N. Fernández-Ros, M. Iñarrairaegui, 2012, Rare tumors.

Efficacy of transjugular intrahepatic portosystemic shunt to prevent total portal vein thrombosis in cirrhotic patients awaiting for liver transplantation.

B. Sangro, J. Quiroga, F. Rotellar, 2012, Transplantation proceedings.

Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients

G. Blanco-Fernández, C. Fondevila, M. Navasa, 2020, Journal of Hepatology.

Conversion from Calcineurin Inhibitor-Based Immunosuppression to Mycophenolate Mofetil in Monotherapy Reduces Risk of De Novo Malignancies After Liver Transplantation.

B. Sangro, J. Quiroga, F. Rotellar, 2017, Annals of transplantation.

Radioembolization versus chemoembolization for unresectable hepatocellular carcinoma: a meta-analysis of randomized trials

B. Sangro, M. Iñarrairaegui, G. Frassineti, 2018, OncoTargets and therapy.

Radioembolisation in patients with hepatocellular carcinoma that have previously received liver-directed therapies

F. Izzo, B. Sangro, F. Fiore, 2018, European Journal of Nuclear Medicine and Molecular Imaging.

Clinical characteristics of hepatocellular carcinoma in Spain. Comparison with the 2008-2009 period and analysis of the causes of diagnosis out of screening programs. Analysis of 686 cases in 73 centers.

J. Bruix, J. Crespo, B. Mínguez, 2017 .

Rhabdomyolysis after Intentional Acetaminophen and Carbon Monoxide Poisoning

B. Sangro, J. Quiroga, J. Herrero, 2012 .

Lung cancer screening with low-radiation dose computed tomography after liver transplantation.

G. Bastarrika, J. Quiroga, J. Herrero, 2013, Annals of transplantation.

Locoregional Transarterial Therapies for Hepatocellular Carcinoma: Transarterial Chemoembolization and Radioembolization

B. Sangro, D. D’Avola, M. Iñarrairaegui, 2013, Visceral Medicine.

Usefulness of a program of neoplasia surveillance in liver transplantation. A preliminary report

J. Prieto, B. Sangro, J. Quiroga, 2009, Clinical transplantation.

O110 AN INTERNATIONAL COLLABORATIVE STUDY ASSESSING THE ROLE OF AETIOLOGY AND STAGE IN SURVIVAL IN HCC – IMPLICATIONS FOR SCREENING

B. Sangro, W. Yeo, P. Johnson, 2014 .

Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade

B. Sangro, W. Yeo, H. Reeves, 2016, British Journal of Cancer.

HepaVac-101 first-in-man therapeutic cancer vaccine phase I/II clinical trial for hepatocellular carcinoma patients.

H. Rammensee, M. Loeffler, E. Simeone, 2018 .

Partial liver volume radioembolization induces hypertrophy in the spared hemiliver and no major signs of portal hypertension.

B. Sangro, F. Rotellar, D. D’Avola, 2014, HPB : the official journal of the International Hepato Pancreato Biliary Association.

Decreased Long-term SARS-CoV-2-Specific Humoral Immunity in Liver Transplant Recipients 12-Months after COVID-19.

G. Blanco-Fernández, V. Cuervas-Mons, S. Tomé, 2021, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Phase I/II multicenter trial of a novel therapeutic cancer vaccine, HepaVac-101, for hepatocellular carcinoma.

F. Izzo, P. Ascierto, L. Buonaguro, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Is a Technetium-99m Macroaggregated Albumin Scan Essential in the Workup for Selective Internal Radiation Therapy with Yttrium-90? An Analysis of 532 Patients.

B. Sangro, J. Bilbao, V. Morán, 2017, Journal of vascular and interventional radiology : JVIR.

Spontaneous regression of hepatocellular carcinoma: a systematic review

B. Sangro, F. Guillén-Grima, M. Iñarrairaegui, 2009, European journal of gastroenterology & hepatology.

[Treatment of chronic hepatitis C virus infection].

M. Iñarrairaegui, J. Zozaya, I. Elizalde, 2004, Anales del sistema sanitario de Navarra.

Liver transplantation in patients with hepatocellular carcinoma across Milan criteria

J. Prieto, B. Sangro, J. Quiroga, 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

The Pattern of Progression Defines Post-progression Survival in Patients with Hepatocellular Carcinoma Treated with SIRT

B. Sangro, A. Casadei‐Gardini, J. Herrero, 2020, CardioVascular and Interventional Radiology.

Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion

B. Sangro, T. Meyer, W. Yeo, 2017, British Journal of Cancer.

Liver Resection and Transplantation Following Yttrium-90 Radioembolization for Primary Malignant Liver Tumors: A 15-Year Single-Center Experience

B. Sangro, F. Rotellar, J. Herrero, 2023, Cancers.

A comparison of survival in patients with hepatocellular carcinoma and portal vein invasion treated by radioembolization or sorafenib

B. Sangro, J. Arenas, M. Iñarrairaegui, 2016, Liver international : official journal of the International Association for the Study of the Liver.

Analysis of prognostic factors after yttrium-90 radioembolization of advanced hepatocellular carcinoma.

J. Prieto, B. Sangro, J. Quiroga, 2010, International journal of radiation oncology, biology, physics.

Spontaneous Regression of Hepatocellular Carcinoma: Three Case Reports and a Categorized Review of the Literature

B. Sangro, F. Alegre, J. Vila, 2009, Digestive Diseases and Sciences.

Increased liver stiffness values in patients with heart failure.

J. Prieto, B. Sangro, J. Quiroga, 2013, Acta gastro-enterologica Belgica.

Tumour recurrence after Interferon-free treatment for hepatitis C in patients with previously treated hepatocellular carcinoma discloses a more aggressive pattern and faster tumour growth

J. Bruix, X. Forns, B. Sangro, 2017 .

Acute generalized exanthematous pustulosis induced by sorafenib.

M. Idoate, M. Iñarrairaegui, M. Pretel, 2014, JAMA dermatology.

Acute Generalized Exanthematous Pustulosis Induced by Sorafenib Sorafenib

Phd, M. Iñarrairaegui, M. Pretel, 2014 .

[Abdominal pain and infection by the varicella-zoster virus following bone marrow transplant].

J. Vila, A. Arín, M. Iñarrairaegui, 2002, Anales del sistema sanitario de Navarra.

[Comparison of the M and XL FibroScan(®) probes to estimate liver stiffness by transient elastography].

J. Prieto, B. Sangro, J. Quiroga, 2014, Gastroenterology & hepatology.

3D voxel-based dosimetry to predict contralateral hypertrophy and an adequate future liver remnant after lobar radioembolization

B. Sangro, J. Bilbao, E. Prieto, 2021, European Journal of Nuclear Medicine and Molecular Imaging.

Abstract 4387: Antiviral and antitumoral effects of the anti-CTLA4 agent tremelimumab in patients with hepatocellular carcinoma (HCC) and chronic hepatitis C virus (HCV) infection: Results from a phase II clinical trial

J. Prieto, B. Sangro, I. Melero, 2012 .

A new animal model of atrophy–hypertrophy complex and liver damage following Yttrium-90 lobar selective internal radiation therapy in rabbits

B. Sangro, C. Berasain, J. Bilbao, 2022, Scientific Reports.

Is liver biopsy necessary in the evaluation of a living donor for liver transplantation?

F. Rotellar, P. Martí, J. Herrero, 2014, Transplantation proceedings.

Liver transplantation in patients with hepatocellular carcinoma across Milan criteria.

B. Sangro, J. Quiroga, F. Rotellar, 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Transarterial therapies for hepatocellular carcinoma

B. Sangro, D. D’Avola, M. Iñarrairaegui, 2011, Expert opinion on pharmacotherapy.

Selective internal radiation therapy (SIRT) using Y90 resin microspheres as consolidation treatment for liver metastases from colorectal cancer (LCRC).

B. Sangro, F. Rotellar, J. Bilbao, 2015 .

Subsequent nonmelanoma skin cancer after liver transplantation.

B. Sangro, F. Rotellar, J. Herrero, 2012, Transplantation proceedings.

Prognostic factors and prevention of radioembolization‐induced liver disease

B. Sangro, J. Quiroga, J. Herrero, 2013, Hepatology.

Selective Internal Radiation Therapy Approval for Early HCC: What Comes Next?

B. Sangro, M. Iñarrairaegui, 2021, Hepatology.

Trial of complete weaning from immunosuppression for liver transplant recipients: Factors predictive of tolerance

B. Sangro, J. Quiroga, J. Herrero, 2013, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

J. Bruix, J. Crespo, B. Mínguez, 2017, Medicina clinica.

Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study.

Jakob Nikolas Kather, N. Loménie, J. Pawlotsky, 2023, The Lancet. Oncology.

Identification of neoantigen-reactive T cells in hepatocellular carcinoma: implication in adoptive T cell therapy

B. Sangro, Ibon Tamayo, S. Hervás-Stubbs, 2020, Journal of Hepatology.

Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment

C. Berasain, D. D’Avola, M. Iñarrairaegui, 2023, Clinical and molecular hepatology.

Comprehensive in silico CpG methylation analysis in hepatocellular carcinoma identifies tissue- and tumor-type specific marks disconnected from gene expression.

C. Berasain, M. Fernández-Barrena, M. Iñarrairaegui, 2024, Journal of physiology and biochemistry.